Singapore to start clinical trials for monoclonal antibody against COVID-19
Singapore will begin human clinical trials to evaluate TY027, a monoclonal antibody (mAb) that specifically targets SARS-CoV-2, the virus which causes COVID-19 next week.
Illustrative image (Source: The Strait Times)Singapore (VNA) - Singapore will begin human clinical trials to evaluate TY027, a monoclonal antibody (mAb) that specifically targets SARS-CoV-2, the virus which causes COVID-19 next week.
The trials of TY027, developed by Singapore-based biotechnology company Tychan, will be conducted on 23 healthy individuals for a potential treatment for COVID-19. It aims to slow the progression of the disease and accelerate recovery, as well as for its potential to provide temporary protection against infection with SARS-CoV-2.
The first phase of the trials will be carried out by the SingHealth Investigational Medicine Unit for about six weeks to determine the safety and effectiveness of TY027.
If this phase is successful, Tychan will seek approval for the antibody to be administered to a larger population of volunteer patients in subsequent trials.
Professor Ooi Eng Eong of Duke-NUS Medical School, who is one of the founders of Tychan, said that TY027 could be used not only to treat COVID-19 patients but also to prevent infections.
"If the drug is indeed safe enough, we could, for instance, give (it) to healthcare workers who are treating COVID-19 patients so they don't get the infections themselves.
"And, as well as other scenarios like, for instance, if one travels to places with a lot of COVID-19 cases, this could be used to prevent infections when they are away from Singapore," he said.
Monoclonal antibodies are immune system proteins that are created in the laboratory, and can be specially designed and engineered to target SARS-CoV-2./.
You should also see
Energy industry needs nearly 5 trillion VND of investment in 2021-2030
The total investment capital demand for the whole energy sector in the 2021-2030 period is between 4.13-4.8 trillion VND (163.01-189.46 million USD), according to a plan to implement the National Power Planning in the 2021-2030 period with a vision to 2050.
See more
World
Thailand expects wave of tourists during Golden Week
The Tourism Authority of Thailand (TAT) estimates that about 996,000 foreign tourists will visit the Southeast Asian country between April 26 and May 5, known as the Golden Week holidays in Japan, during which Chinese tourists also prefer to travel overseas.
World
Argentinian media praises Dien Bien Phu Victory
Argentinian newspapers have called Vietnam's Dien Bien Phu Victory (May 7, 1954) a symbol of the national liberation movement of oppressed and colonialised peoples worldwide.
World
Laos speeds up granting licences to foreign workers
Laos's Ministry of Labour and Social Welfare plans to issue visas to illegal foreign workers and extend permits to legal ones so that they can continue to work in the country.
World
Argentinian scholar praises Vietnam’s April 30, 1975 victory
The complete reunification of Vietnam on April 30, 1975 was an extremely significant event in the history of the country and the world, opined a scholar from the Institute for International Relations at the National University of La Plata, Argentina.
World
Malaysia tackles food security challenges
Empowering local communities in the agriculture sector to attract young people to this field is one of the measures taken by Malaysia to address labour shortage while also contributing to tackling challenges in food security.
